Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average of ...

Shares of Abbott Laboratories ABT rallied 1.07% to $122.55 Wednesday, on what proved to be an all-around great trading ...

Records from December 9, 2025 indicate that Representative Richard Dean Dr McCormick of Georgia made a purchase of Abbott ...

Like all its peers, Abbott Laboratories ABT faced the industrywide challenges of margin pressure through 2024, stemming from growing inflation, labor shortages and supply chain disruptions, which ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Abbott Laboratories’ stock narrative is shifting as analysts adjust their consensus price target, which has edged down slightly from $144.47 to $144.43. This recent update comes alongside a range of ...

An announcement from Abbott Laboratories ( ($ABT) ) is now available. On December 12, 2025, Abbott Laboratories announced the ...

Abbott (NYSE: ABT) recently reported its Q2 results, with revenues and earnings exceeding our expectations. The company reported revenue of $10.4 billion and earnings of $1.14 on a per-share and ...

Abbott (NYSE: ABT) will report its Q2 2024 results on Thursday, July 18. We expect the company to post revenue of $10.3 billion and earnings of $1.10 on a per share and adjusted basis, broadly ...

Abbott Laboratories is now a $183 billion (by market cap) healthcare titan. Abbott Laboratories has increased its dividend for more than 50 consecutive years. So it has the kind of dividend growth ...

This was the stock's second consecutive day of losses.